Date: 04 Nov 2010
Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
You are viewing the full content
Erratum to: J Cancer Surviv
The references in the original article have been published incorrectly. The correct version is provided below.
The online version of the original article can be found at http://dx.doi.org/10.1007/s11764-010-0141-y.
- American Cancer Society. Colorectal cancer facts and figures 2008–2010. 2009.
- Gross CP. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006;54(12):1898–904. CrossRef
- Yancik R. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998;82(11):2123–34. CrossRef
- Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al. SEER Cancer Statistics Review, 1975–2005. 2007.
- Williams JC. Colon carcinoma and diabetes mellitus. Cancer. 1984;54(12):3070–1. CrossRef
- O’Mara BA. Diabetes mellitus and cancer risk: a multisite case-control study. J Chron Dis. 1985;38(5):435–41. CrossRef
- La VC. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomark Prev. 1997;6(12):1007–10.
- La VC. History of selected diseases and the risk of colorectal cancer. Eur J Cancer. 1991;27(5):582–6. CrossRef
- Nilsen TI. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84(3):417–22. CrossRef
- Meyerhardt JA. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21(3):433–40. CrossRef
- Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754–64. CrossRef
- Siddiqui AA. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci. 2008;53(9):286–94.
- Keating NL. Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007;45(9):869–75. CrossRef
- Wattacheril J. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008;28(9):1166–74. CrossRef
- Deyo RA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–19. CrossRef
- Arnold N, Sohn M, Maynard C, Hynes DM. VIReC technical Report 2: VANDI Mortality Data Merge Project. 4-9-2006.
- El-Serag HB. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009;136(5):1601–8. CrossRef
- Polednak AP. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006;30(5):466–72. CrossRef
- Shonka NA. Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2006;23(4):515–19. CrossRef
- Kerr EA. Making performance indicators work: experiences of US Veterans Health Administration. BMJ. 2007;335(7627):971–3. CrossRef
- Jha AK. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003;348(22):2218–27. CrossRef
- Nattinger AB. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326(17):1102–7. CrossRef
- Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
Journal of Cancer Survivorship
Volume 5, Issue 1 , p 113
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Houston Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA
- 2. Department of Medicine, Baylor College of Medicine, Houston, TX, USA
- 3. Houston Center for Quality of Care and Utilization Studies, Michael E. DeBakey VA Medical Center (152), 2002 Holcombe Boulevard, Houston, TX, 77030, USA